Invention Grant
- Patent Title: Aminopyrazole derivatives as GSK-3 inhibitors
- Patent Title (中): 氨基吡唑衍生物作为GSK-3抑制剂
-
Application No.: US10580615Application Date: 2004-11-15
-
Publication No.: US07671072B2Publication Date: 2010-03-02
- Inventor: John W. Benbow , Daniel W. Kung
- Applicant: John W. Benbow , Daniel W. Kung
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Gregg C. Benson; John A. Wichtowski
- International Application: PCT/IB2004/003749 WO 20041115
- International Announcement: WO2005/051919 WO 20050609
- Main IPC: A61K31/4155
- IPC: A61K31/4155 ; A61K31/435 ; C07D401/02 ; C07D231/10
Abstract:
The present invention provides compounds of formula (I) the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein R1, R2, and R3 are as defined herein; pharmaceutical compositions thereof; combinations thereof; and uses thereof in the treatment of, inter alia, conditions, diseases, and symptoms including, inter alia, Alzheimer's Disease, cancer, dementia, depression, diabetes, hair loss, schizophrenia, and stroke.
Public/Granted literature
- US20070276010A1 Aminopyrazole Derivatives as Gsk-3 Inhibitors Public/Granted day:2007-11-29
Information query
IPC分类:
